PUSH THE BOUNDS OF SCIENCE
Seeking to solve the human body’s most complex mysteries
Regeneron is a leading biotechnology company dedicated to inventing, developing and commercializing medicines for people with serious diseases. Our mission is to use the power of science to bring new medicines to patients … over and over again.
Founded and led by physician-scientists since 1988, Regeneron has more than 15,000 employees around the world, with locations in North America, Europe and Asia. Regeneron-invented medicines are available in over 100 countries and are being studied in clinical trials in approximately 60 countries.
Our ability to repeatedly translate science into medicine has led to numerous medicines authorized by regulatory agencies around the world and dozens of investigational product candidates in development, almost all of which were homegrown in our laboratories.
In addition to our medicines, our innovations include the VelociSuite® drug discovery and development technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good.
LEARN ABOUT OUR COLLABORATIONS
View our collaborative working projects or contact us to find out more.
BE AN ENGINE OF INNOVATION
We embrace progress in science, in manufacturing and in what people can expect from their health. Help us turn science into medicine.
The information provided on this website is for UK residents only. Please contact your healthcare provider for any medical advice.
